Financials data is unavailable for this security.
View more
Year on year Pacific Biosciences of California Inc grew revenues 56.29% from 128.30m to 200.52m while net income improved from a loss of 314.25m to a smaller loss of 306.74m.
Gross margin | 26.01% |
---|---|
Net profit margin | -211.99% |
Operating margin | -226.21% |
Return on assets | -23.85% |
---|---|
Return on equity | -70.57% |
Return on investment | -26.63% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Pacific Biosciences of California Inc fell by 145.68m. Cash Flow from Financing totalled 108.89m or 54.30% of revenues. In addition the company used 259.17m for operations while cash from investing totalled 4.60m.
Cash flow per share | -1.38 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.81 |
---|---|
Tangible book value per share | -1.17 |
More ▼
Balance sheet in USDView more
Current ratio | 8.01 |
---|---|
Quick ratio | 7.14 |
Total debt/total equity | 1.81 |
---|---|
Total debt/total capital | 0.6444 |
More ▼